Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO GI 2021 | Next steps in gastric cancer

Zev Wainberg • 15 Jan 2021
ASCO GI 2021
Gastric Cancer Gastrointestinal Cancer
FIGHT

Zev Wainberg, MD, University of California Los Angeles, Los Angeles, CA, discusses upcoming advances in gastric cancer, including a renewed interest in the FGFR signalling pathway on the heels of the FIGHT study (NCT03694522), and the importance of understanding overlapping biomarkers in gastric cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Zev Wainberg

0:43
daNIS-2: NIS793 with nab-paclitaxel and gemcitabine in mPDAC
Zev Wainberg • 20 Jan 2023
0:32
DKN-01 with bevacizumab and chemotherapy in advanced CRC
Zev Wainberg • 20 Jan 2023
0:54
NAPOLI-3: first-line NALIRIFOX in metastatic pancreatic ductal adenocarcinoma
Zev Wainberg • 20 Jan 2023
0:48
Current and future directions in gastric cancer research
Zev Wainberg • 12 Apr 2022

Related Videos

2:11
COMPASSION-15: cadonilimab in advanced gastric cancers
Yelena Janjigian • 8 Apr 2024
1:28
Evolving biomarker driven therapies to overcome gastric cancer tumor resistance
Yelena Janjigian • 8 Apr 2024
0:56
Adjuvant chemotherapy in biliary tract cancer post-tumor resection
Olatunji Alese • 8 Apr 2024
0:40
The limited therapeutic efficacy of checkpoint inhibitors for pancreatic cancer
Olatunji Alese • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals